Malaysia vs North Macedonia: Access to anti-retroviral drugs, male
Malaysia
59.0%
in 2024
North Macedonia
60.0%
in 2024
Malaysia rank
105th
North Macedonia rank
102nd
Access to anti-retroviral drugs, male over time
- Malaysia
- North Macedonia
How they compare
North Macedonia currently reports 60.0% against 59.0% in Malaysia, a difference of 1.0%.
The two have swapped places 6 times across 25 shared years of data; in 2000 it was North Macedonia ahead.
Malaysia ranks 105th and North Macedonia ranks 102nd of 141 countries.
North Macedonia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Malaysia | North Macedonia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 7.2% | 9.6% | 2.4% | North Macedonia |
| 2010s | 29.7% | 33.3% | 3.6% | North Macedonia |
| 2020s | 55.6% | 55.8% | 0.2% | North Macedonia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Malaysia or North Macedonia?
- North Macedonia, at 60.0% against 59.0% in Malaysia as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Malaysia and North Macedonia?
- 1.0%, with North Macedonia ahead.
- How many years of comparable data are there for Malaysia and North Macedonia?
- 25 years are reported by both, from 2000 to 2024.
- How do Malaysia and North Macedonia rank globally for access to anti-retroviral drugs, male?
- Malaysia ranks 105th and North Macedonia ranks 102nd of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.